Radiation boost may extend life in lung cancer that has spread to a few spots

NCT ID NCT05278052

Recruiting now Disease control Sponsor: Tata Memorial Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This phase 3 trial tests whether adding targeted radiation to all cancer spots (up to 5) improves survival in people with non-small cell lung cancer that has spread to a few places. Participants receive either standard maintenance therapy alone or standard therapy plus radiation. The study aims to enroll 190 adults and will measure overall survival and how long the cancer stays controlled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: radiation therapy
What this could lead to: If successful, adding radiation to standard therapy could help people with limited metastatic lung cancer live longer and control the disease better.
What could go wrong: This is a mid-stage trial with 190 participants, so results may not apply to everyone. Radiation can cause side effects, and it is not yet known if it will improve survival.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for METASTATIC NON-SMALL CELL LUNG CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

METASTATIC NON-SMALL CELL LUNG CANCER OLIGOMETASTATIC DISEASE

Contacts and locations

Locations

Tata Memorial Hospital, Parel
RECRUITING

Mumbai, Maharashtra, 400012, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.